PharmaTher Granted Pre-IND Meeting with the FDA for Ketamine in Parkinson’s Disease Post published:December 10, 2020 Post category:Press Release
Mind Cure Moves into Psychedelic Assisted Therapy with British Columbia Location Offering Ketamine and Psilocybin Therapy Post published:December 10, 2020 Post category:Press Release
CaaMTech Expands Successful Next-Gen Drug Research Collaboration with UMass Dartmouth Post published:December 9, 2020 Post category:Press Release
Usona Institute Publishes Synthesis and Characterization of cGMP 5-MeO-DMT Post published:December 9, 2020 Post category:Press Release
Red Light Holland Announces Intention to Acquire Controlling Interest in Psychedelic Insights Providing Psychological Guidance of Psychedelic Experiences with Truffles in the Netherlands Post published:December 9, 2020 Post category:Press Release
Entheon Biomedical Announces DMT Drug Supply Agreement with Psygen Labs Inc. Completion of Initial DMT Research Drug Batch and Exercise of Warrants Post published:December 9, 2020 Post category:Press Release
MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing Post published:December 9, 2020 Post category:Press Release
BetterLife adds Next-Gen Psychedelic Therapy to its Pipeline of Drugs Post published:December 9, 2020 Post category:Press Release
Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham Post published:December 9, 2020 Post category:Press Release
PharmaTher Files FDA Pre-IND Meeting Request for Ketamine in Parkinson’s Disease Post published:December 9, 2020 Post category:Press Release